Medical writing in India at a crossroads

Salil Bose

Volume 22, Issue 2 - Medical Writing Around the World

Medical writing in India at a crossroads

Author: Salil Bose

Abstract

Pharmaceutical regulatory medical writing for document submissions to Western health regulatory agencies has been undertaken in India for almost 10 years. From humble beginnings in a couple of non-Indian pharmaceutical multinational giants – Novartis and Sanofi-Aventis (as it was) – this activity has now expanded into multiple companies and almost a dozen information technology firms and contract research organisations. The biggest advantage is the cost, although this often comes at a ‘price’, in terms of document quality. However, medical writing in India may be turning a corner for the good as a result of the rapidly increasing body of experience in the field.

Keywords: Medical writing, india, outsourcing, quality, Cost arbitrage

Download the full article

References

Task force report. India as knowledge superpower: Strategy for transformation. New Delhi: Planning Commission, Government of India, 2001 [cited 28 February 2013] Available from: http://planningcommission.nic.in/aboutus/taskforce/tk_know.pdf
Ernst and Young. The glorious metamorphosis: compelling reasons for doing clinical research in India.1, 2009. [cited 28 February 2013]. Available from: http://www.ficci.com/publication-page.asp?spid=20026
Vale RD, Dell K. The biological sciences in India: aiming high for the future. J Cell Biol 2009;184(3):342–53.
Reeves A. Why do we need medical writers, editors and translators? Srp Arh Celok Lek 2008;136(1–2):80–1.

Volume 22, Issue 2 - Medical Writing Around the World

Medical writing in India at a crossroads

Author: Salil Bose

Abstract

References

Search

Articles

Member Login

Links

Editoral Board